Pharmaceutical companies operate in a highly regulated environment where patient safety remains the highest priority. Once a medicine is approved and enters the market, companies are expected to continuously monitor its safety profile, identify potential risks, and report safety information to regulatory authorities.
To ensure that these responsibilities are fulfilled, regulators require pharmaceutical companies to establish a functional pharmacovigilance system. At the center of this system is the Qualified Person for Pharmacovigilance (QPPV) — a key role responsible for overseeing drug safety activities and ensuring regulatory compliance.
For Marketing Authorization Holders (MAHs), the QPPV serves as the individual accountable for the overall performance of the pharmacovigilance system and the company’s ability to meet regulatory safety obligations.
What is a Qualified Person for Pharmacovigilance (QPPV)?
A Qualified Person for Pharmacovigilance (QPPV) is a designated pharmacovigilance professional responsible for establishing, maintaining, and overseeing a company’s pharmacovigilance system. Regulatory authorities require pharmaceutical companies to appoint a QPPV with the necessary qualifications, experience, and authority to ensure that safety monitoring activities are properly conducted.
The QPPV ensures that the company has systems, procedures, and trained personnel in place to monitor the safety of medicinal products throughout their lifecycle. This includes managing the collection, evaluation, and reporting of adverse drug reactions, as well as maintaining regulatory safety documentation.
In many jurisdictions, the QPPV also acts as the primary contact person for regulatory authorities on pharmacovigilance matters, ensuring that regulators can quickly access safety information when required.
Key Responsibilities of the QPPV
The responsibilities of a QPPV extend across the entire pharmacovigilance system of a pharmaceutical company. While the structure of the system may vary depending on the size of the organization and the number of products marketed, the QPPV is responsible for ensuring that all pharmacovigilance activities function effectively and comply with regulatory requirements.
Core responsibilities of the QPPV typically include:
Oversight of adverse event reporting, ensuring that Individual Case Safety Reports (ICSRs) are collected, assessed, and reported to regulatory authorities within required timelines
Supervision of literature monitoring activities, ensuring that relevant scientific and local literature are screened for potential safety information
Evaluation of emerging safety signals and coordination of signal detection and risk evaluation activities
Ensuring submission of regulatory safety reports, including Periodic Safety Update Reports (PSURs) and other safety documentation
Maintenance of the Pharmacovigilance System Master File (PSMF), which describes the company’s pharmacovigilance system and processes
Support during pharmacovigilance inspections and audits conducted by regulatory authorities
Through these responsibilities, the QPPV ensures that the company maintains continuous oversight of product safety and fulfills its regulatory commitments.
The Strategic Importance of the QPPV
Beyond regulatory compliance, the QPPV plays a strategic role in ensuring that pharmaceutical companies maintain a proactive approach to drug safety. Effective pharmacovigilance allows companies to detect potential safety risks early, evaluate benefit–risk profiles, and implement appropriate risk minimization measures.
A well-functioning pharmacovigilance system under the leadership of a competent QPPV helps companies to:
Maintain regulatory compliance across different markets
Ensure timely detection and management of safety risks
Protect patients through continuous safety monitoring
Maintain regulatory and stakeholder confidence in their products
In today’s regulatory landscape, authorities are placing greater emphasis on accountability and transparency in pharmacovigilance systems. The QPPV therefore plays a central role in demonstrating that the company’s safety monitoring processes are robust and effective.
QPPV Requirements for Pharmaceutical Companies
Regulatory authorities expect the QPPV to possess appropriate qualifications and experience in pharmacovigilance and drug safety. Typically, a QPPV should have a professional background in medicine, pharmacy, or life sciences, along with a strong understanding of pharmacovigilance regulations and Good Pharmacovigilance Practice (GVP) guidelines.
In addition to technical expertise, the QPPV must also have sufficient authority within the organization to influence safety-related decisions and ensure that pharmacovigilance obligations are prioritized.
Companies must ensure that the QPPV is supported by an adequate pharmacovigilance structure, appropriate documentation, and clear operational procedures.
When Pharmaceutical Companies Consider Outsourcing QPPV Services
For many pharmaceutical companies, particularly those expanding into new markets or managing multiple product portfolios, maintaining a full in-house pharmacovigilance infrastructure can be complex and resource-intensive.
As a result, many organizations choose to work with specialized pharmacovigilance service providers who can support or manage QPPV responsibilities. This approach allows companies to access experienced pharmacovigilance professionals while maintaining a compliant safety system.
Outsourcing QPPV services can support companies in areas such as:
Establishing a compliant pharmacovigilance system
Maintaining the Pharmacovigilance System Master File (PSMF)
Managing safety reporting and regulatory submissions
Providing pharmacovigilance oversight across multiple countries
Supporting regulatory inspections and compliance activities
This model allows pharmaceutical companies to maintain regulatory compliance while focusing on their core activities such as product development, commercialization, and market expansion.
Strengthening Your Pharmacovigilance System with the Right Partner
As pharmacovigilance requirements continue to evolve globally, pharmaceutical companies must ensure that their drug safety systems remain compliant, responsive, and inspection-ready. Establishing a strong QPPV function is therefore not only a regulatory requirement but also a critical component of responsible pharmaceutical practice.
At IntraHub Africa, we support pharmaceutical companies with comprehensive pharmacovigilance services, including QPPV and Local Person for Pharmacovigilance (LPPV) support, pharmacovigilance system setup, literature monitoring, safety case management, and regulatory safety reporting. Our technology-enabled pharmacovigilance infrastructure and experienced drug safety professionals help companies maintain regulatory compliance while ensuring effective monitoring of product safety across markets.
By partnering with IntraHub Africa, pharmaceutical companies can strengthen their pharmacovigilance systems, remain compliant with evolving regulatory expectations, and maintain a strong commitment to patient safety.